Novartis India Limited (NOVARTIND)
₹0
INR+NA(+NA%)
As of November 25, 2024 12:34:00 PMAbout Novartis India Limited
Novartis India Limited operates as a healthcare company in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neurosciences products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is based in Mumbai, India. The company is a subsidiary of Novartis AG.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
5.06
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
26.15
+-13.8% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
1747.71 CrINR
Total market value of the company's outstanding shares
Employees
62
Total number of full-time employees worldwide
CEO
NA
Chief Executive Officer of the company